Hepatocellular carcinoma (HCC) remains a major clinical challenge due to its late diagnosis and poor prognosis. To address these limitations, we developed a novel gefitinib derivative (DCQ-Me) and integrated it into a multifunctional fluorescent nanosystem, AL... ...

请注册登录后继续浏览